About Index Trending news
Lists
Pricing
Critical Outcome Technologies

Critical Outcome Technologies

Critical Outcome Technologies

Multiple clinical trials planned for COTI-2, our p53-dependent, potential breakthrough treatment for many cancers. | Listed on the TSX Venture Exchange as COT.
Founded
1999
Raised
$1.6M
Follow us
Alexa global traffic share